![Ryan Bond](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 158 400 $ al 30/06/2026
Ryan Bond is currently Chief Strategy Officer at Aclarion, Inc., a position started in 2021.
Formerly, Mr. Bond was Director-Healthcare Solutions at NuVasive LLC from 2014 to 2018.
Mr. Bond completed undergraduate education at The Ohio University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ACLARION, INC. 2,23 % | 11/06/2026 | 55.000 ( 2,23 % ) | 158 400 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ACLARION, INC. | Corporate Officer/Principal | 15/09/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| NUVASIVE, INC. | Corporate Officer/Principal | 01/09/2018 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices for the surgical treatment of spine disorders | Health Technology |
Aclarion, Inc.
 Aclarion, Inc. Packaged SoftwareTechnology Services Develops investigational software to analyze chemical makeup of intervertebral discs in spine | Technology Services |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
